← FDA DRUG APPROVALS

FDA NDA · NDA050523

VIRA-A

Sponsor: PARKEDALE

APPLICATION
NDA050523
TYPE
NDA
ORIGINAL APPROVAL
1978-10-18
LATEST ACTION
1978-10-18
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

VIRA-ADiscontinued
VIDARABINE EQ 187.4MG BASE/ML · INJECTABLE · INJECTION

Approval history

1978-10-18Type 3 - New Dosage Form · Original · priorityAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →